GHRP-2
Pralmorelin
A synthetic ghrelin-mimetic hexapeptide (pralmorelin) that activates the growth-hormone-secretagogue receptor (GHS-R1a) to stimulate pituitary growth hormone release; used diagnostically in some countries.
Half-life
Short; ~30 min (approximate), subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied lyophilized; store cool, reconstitute before use, then refrigerate and protect from light.
References
- Peer-reviewed GHS-R1a pharmacology
- Ishida et al. 2020
Related in Growth Hormone
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.